year which posted total net loss Baht 1,401 million. Revenue from sale of goods amounted to Baht 5,192 million, decreased by Baht 2,623 million or 34% YoY. Separate financial statement, the Company had
. Net income (loss) 10. Earnings per share 10.1 Basic earning per share 10.1.1 Net profit (loss) before extraordinary items 10.1.2 Extraordinary items 10.1.3 Net income (loss) 10.2 diluted earning per
minority interest 7. Profit (Loss) from ordinary activities 8. Extraordinary Items 9. Net income (loss) 10. Earnings per share 10.1 Basic earning per share 10.1.1 Net profit (loss) before extraordinary items
. Net profit (Loss) of minority interest 7. Profit (Loss) from ordinary activities 8. Extraordinary Items 9. Net income (loss) 10. Earnings per share 10.1 Basic earning per share 10.1.1 Net profit (loss
Medical Business Plc., (CMR) amount Baht 1,010.31 million. comparing at the same period in 2017 representing 18.19% increase. Income from medical treatments in the separate financial went up 17.07% due to
Chiang Mai Ram Medical Business Plc., (CMR) amount Baht 995.22 million comparing at the same period in 2018 representing 1.86% increase . Income from medical treatments in the separate financial went up
Derivatives Act B.E. 2546 (2003). - The SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint
Act B.E. 2546 (2003). - The SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint against
). - The SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint against each alleged offender and
Derivatives Act B.E. 2546 (2003). - The SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint